Tidal Investments’s Corcept Therapeutics CORT Stock Holding History

Tidal Investments’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$894K	Buy	22,179 +9,684	+78%	+$362K	﹤0.01%	1534
2025 Q4	$435K	Sell	12,495 -1,000	-7%	-$78.5K	﹤0.01%	1713
2025 Q3	$1.12M	Sell	13,495 -10	-0.1%	-$724	﹤0.01%	1160
2025 Q2	$991K	Buy	13,505 +3,470	+35%	+$252K	0.01%	1043
2025 Q1	$1.15M	Buy	+10,035	New	+$611K	0.01%	922
2023 Q2	–	Sell	-56,111	Closed	-$1.22M	–	1319
2023 Q1	$1.22M	Sell	56,111 -10,184	-15%	-$223K	0.04%	426
2022 Q4	$1.35M	Buy	+66,295	New	+$1.66M	0.05%	359

Other funds holding CORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Tidal Investments's CORT Position: Q1 2026 in Review

Tidal Investments increased its Corcept Therapeutics (CORT) stake by 78% in Q1 2026, buying an estimated $362K and bringing the position to 22,179 shares worth $894K. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

Tidal Investments first reported a position in CORT in Q4 2022 and has held it in 7 quarters since. The position peaked at $1.35M in Q4 2022. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

Tidal Investments held 22,179 shares of Corcept Therapeutics worth $894K as of Q1 2026.
Tidal Investments bought 9,684 Corcept Therapeutics shares in Q1 2026, an estimated $362K.
Corcept Therapeutics made up ﹤0.01% of Tidal Investments's portfolio in Q1 2026, its #1534 holding.
Tidal Investments first reported a position in Corcept Therapeutics in Q4 2022 and has held it in 7 quarters since.
Tidal Investments's Corcept Therapeutics position peaked at $1.35M in Q4 2022.
351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.